Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-24 @ 5:56 PM
NCT ID:
NCT02670668
Eligibility Criteria:
Inclusion Criteria:
Patients receiving neoadjuvant chemotherapy with paclitaxel and carboplation are enrolled in this study.
* (1) histologically confirmed mainly invasive breast carcinoma
* (2) a unilateral and non-inflammatory tumors
* (3) status of ER, PR and HER-2 are available and negative
* (4) The participants are required to have clinical stage II or III breast cancer with a clinical or radiographically measurable residual tumor after core biopsy.
* (5)patients had pathological evaluation after NAC
* (6) the pathologic tissues are available for immunohistochemistry and next generation sequencing
Exclusion Criteria:
* (1) carcinoma in situ
* (2) received less than 4 cycles neoadjuvant chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02670668
Study Brief:
Protocol Section:
NCT02670668